We thank Drs Fournier and Muller for their comments on our recent article describing the circadian variation in infarct size in patients with ST-elevation myocardial infarction (STEMI). 1 Their recent observations demonstrating that infarct size (peak creatine kinase) was significantly higher between midnight and 6:00 AM in a cohort of 353 consecutive STEMI patients treated with primary percutaneous coronary intervention 2 support our results.
Response to the Letter by Fournier and Muller
Response:
We thank Drs Fournier and Muller for their comments on our recent article describing the circadian variation in infarct size in patients with ST-elevation myocardial infarction (STEMI). 1 Their recent observations demonstrating that infarct size (peak creatine kinase) was significantly higher between midnight and 6:00 AM in a cohort of 353 consecutive STEMI patients treated with primary percutaneous coronary intervention 2 support our results.
We agree with the authors that variations in care during off hours resulting in different door-to-balloon times and symptom onset-to-reperfusion times could outweigh any effect of circadian variation on infarct size. However, regional transfer systems for primary percutaneous coronary intervention in STEMI such as ours have the ability to abolish these potential off-hours issues. 3 All STEMI patients who present to the referring hospitals are transferred to our institution for primary percutaneous coronary intervention regardless of time of presentation, and no significant difference in pharmacological therapy or transfer times occur in those patients transferred at night versus day, as outlined in the article. Although the performance of the medical team and interventional cardiologist would be difficult to quantify, we found no difference in outcomes in those patients regarding reperfusion time and successful revascularization that has been previously ascribed as a cause for poor outcomes in patients treated during off hours. 4 Although Fournier et al suggested measuring additional parameters to evaluate system performance, we believe they have significant shortcomings. The number of stents placed is largely influenced by extent of disease and ischemic territory, which has been corrected for in our article by cardiac magnetic resonance imaging. Although a larger number of stents might reflect a more complete revascularization, it does not necessarily translate into improved outcomes in a STEMI setting. Thrombolysis in myocardial infarction flow after revascularization may be dependent on ischemic time and therefore is an inaccurate measurement for quality of care. We had only six patients in whom the artery could not be opened and they were excluded from our study.
Additionally, Fournier et al pointed out that aspirin usage before STEMI varied throughout the day. However, we believe it is unlikely that it had a major influence on the circadian variation we observed. Patients in the group presenting with the lowest creatine kinase actually had a lower percentage of aspirin use compared with the group of patients with the highest creatine kinase. No statistical correlation between aspirin usage and creatine kinase levels could be demonstrated. Although platelet inhibition by pretreatment with aspirin might result in a higher likelihood of vessel patency and spontaneous revascularization, thereby leading to decreased myocardial damage, we believe this is less of a concern in our population because everyone in our study had a completely occluded artery at presentation. Additionally, all patients received aspirin on presentation to the emergency department. Because the therapeutic effect is generally achieved in Ͻ20 minutes, 5 all patients would have had therapeutic levels of aspirin at time of intervention regardless of previous aspirin usage.
Regarding the comment on the link of melatonin levels and myocardial infarct size, the aim of our investigation was to demonstrate a circadian variation to ischemic tolerance in humans. The mechanisms responsible for this, which may include melatonin levels, were outside the scope of our investigation. It is likely that many metabolites with circadian regulation would show a statistically significant correlation with reperfusion injury. However, this would not necessarily prove causality.
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